摘要
Peripheral artery disease (PAD) biomarkers have been studied in isolation; however, an algorithm that considers a protein panel to inform PAD prognosis may improve predictive accuracy. Biomarker-based prediction models were developed and evaluated using a model development (n = 270) and prospective validation cohort (n = 277). Plasma concentrations of 37 proteins were measured at baseline and the patients were followed for 2 years. The primary outcome was 2 -year major adverse limb event (MALE; composite of vascular intervention or major amputation). Of the 37 proteins tested, 6 were differentially expressed in patients with vs. without PAD (ADAMTS13, ICAM-1, ANGPTL3, Alpha 1-microglobulin, GDF15, and endostatin). Using 10 -fold cross -validation, we developed a random forest machine learning model that accurately predicts 2 -year MALE in a prospective validation cohort of PAD patients using a 6 -protein panel (AUROC 0.84). This algorithm can support PAD risk stratification, informing clinical decisions on further vascular evaluation and management.
学科与关键词
- Development and evaluation of a prediction model for peripheral artery disease-related major adverse limb events using novel biomarker dataLi, Ben; Nassereldine, Rakan; Zamzam, Abdelrahman; Syed, Muzammil H.; Mamdani, Muhammad; Al-Omran, Mohammed; Abdin, Rawand; Qadura, Mohammad*Journal of Vascular Surgery, 2024, 80(2).被引 3
- Predicting outcomes following lower extremity open revascularization using machine learningLi, Ben; Verma, Raj; Beaton, Derek; Tamim, Hani; Hussain, Mohamad A.; Hoballah, Jamal J.; Lee, Douglas S.; Wijeysundera, Duminda N.; de Mestral, Charles; Mamdani, Muhammad; Al-Omran, Mohammed*Scientific Reports, 2024, 14(1): 2899.被引 1
- Predicting Outcomes Following Lower Extremity Endovascular Revascularization Using Machine LearningLi, Ben; Aljabri, Badr; Verma, Raj; Beaton, Derek; Hussain, Mohamad A.; Lee, Douglas S.; Wijeysundera, Duminda N.; de Mestral, Charles; Mamdani, Muhammad; Al-Omran, Mohammed*Journal of the American Heart Association, 2024, 13(9): e033194.
